EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antibiotic perseverance increases the risk of resistance development

Gerrit Brandis iD, Jimmy Larsson iD, Johan Elf

Proceedings of the National Academy of Sciences · 10.01.2023 · 120 (2)

DOI: 10.1073/pnas.2216216120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 03.01.2023. Verfasst von Gerrit Brandis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University 751 24, Uppsala, Sweden. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Escherichia coli. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EC | European Research Council, Swedish Foundation for Strategic Research, Knut och Alice Wallenbergs Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of antibiotic-resistant bacterial infections poses a global threat. Antibiotic resistance development is generally studied in batch cultures which conceals the heterogeneity in cellular responses. Using single-cell imaging, we studied the growth response of Escherichia coli to sub-inhibitory and inhibitory concentrations of nine antibiotics. We found that the heterogeneity in growth increases more than what is expected from growth rate reduction for three out of the nine antibiotics tested. For two antibiotics (rifampicin and nitrofurantoin), we found that sub-populations were able to maintain growth at lethal antibiotic concentrations for up to 10 generations. This perseverance of growth increased the population size and led to an up to 40-fold increase in the frequency of antibiotic resistance mutations in gram-negative and gram-positive species. We conclude that antibiotic perseverance is a common phenomenon that has the potential to impact antibiotic resistance development across pathogenic bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsEscherichia coliMicrobial Sensitivity TestsRifampinMutationBacteriaDrug Resistance, Bacterial

Stichwörter der Autor:innen

antibiotic resistance evolutioncellular heterogeneitymutation frequencyrifampicinsingle-cell microscopy

Substanzen

Anti-Bacterial AgentsRifampin

Autor:innen und Institutionen

  • Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University 751 24, Uppsala, Sweden.

ORCID-Profile: Gerrit Brandis, Jimmy Larsson

Förderung

  • EC | European Research Council
  • Swedish Foundation for Strategic Research
  • Knut och Alice Wallenbergs Stiftelse
  • Vetenskapsrådet

Zitieren

APA

Brandis, G., Larsson, J., & Elf, J. (2023). Antibiotic perseverance increases the risk of resistance development. Proceedings of the National Academy of Sciences, 120(2). https://doi.org/10.1073/pnas.2216216120

Vancouver

Brandis G, Larsson J, Elf J. Antibiotic perseverance increases the risk of resistance development. Proceedings of the National Academy of Sciences. 2023;120(2). doi:10.1073/pnas.2216216120

BibTeX
@article{Brandis2023,
  author = {Brandis, Gerrit and Larsson, Jimmy and Elf, Johan},
  title = {Antibiotic perseverance increases the risk of resistance development},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {2},
  doi = {10.1073/pnas.2216216120}
}
Kostenlos starten →